Show simple item record

dc.contributor.advisorVarón Vega, Fabio Andrés 
dc.creatorMartinez Caballero, Azucena 
dc.date.accessioned2017-08-01T12:12:40Z
dc.date.available2017-08-01T12:12:40Z
dc.date.created2017-02-24
dc.date.issued2017
dc.identifier.urihttp://repository.urosario.edu.co/handle/10336/13595
dc.descriptionIntroducción: Las infecciones por bacilos gram negativos resistentes son frecuentes, más en cuidado intensivo; están asociadas a mayor morbilidad, mortalidad y costos en salud. Nuestro objetivo fue determinar diferencias en mortalidad en pacientes con infecciones por gérmenes gram negativos resistentes versus sensibles, y que factores están asociados. Metodología: Estudio de cohorte retrospectiva, de pacientes adultos con sepsis y choque séptico hospitalizados en la Unidad de Cuidado Intensivo Médico de FCI - FNC entre el año 2012 y 2014, con aislamiento de bacilos gram negativos. Se realizó estadística descriptiva e inferencial de todas las variables y un análisis multivariado para buscar asociaciones con mortalidad. Resultados: Se recolectaron 230 pacientes, 145 (63%) tuvieron aislamiento de bacilos gram negativos resistentes. La tabla 1 muestra las características generales de ambos grupos encontrando que los pacientes con gram negativos resistentes tenían menor edad, sin diferencias en comorbilidad, score de severidad y origen de infección. Los gram negativos resistentes fueron más frecuentes en caso de infección nosocomial (49 Vs 30%, p < 0.001). No se encontraron diferencias en el aislamiento microbiológico, excepto para E. coli sensible (28 Vs 59%, p < 0.001), Grafica 1. En pacientes con gram negativos resistentes fue mayor el tiempo en cuidado intensivo, así como la necesidad de ventilación mecánica; siendo ésta último factor asociado a mortalidad (OR 11.2 IC95% 2.5 – 49.8, p 0.002). Conclusiones: La infección por gérmenes gram negativos resistentes es frecuente, sin diferencias demográficas, ni clínicas con el grupo de infección por gérmenes sensibles. Se asoció con mayor estancia en cuidado intensivo y tiempo de ventilación mecánica, siendo esta última el único factor de riesgo asociado a mortalidad.
dc.description.abstractIntroduction: Resistant gram negative bacilli infections are frequent, more in intensive care; They are associated with a mayor of morbidity, mortality, and health costs. Our objective was to determine differences in mortality in patients with resistant and susceptible gram negative bacterial infections, and which factors are associated. Methodology: Retrospective cohort study of adult patients with sepsis and septic patients hospitalized in the FCI - FNC Medical Intensive Care Unit between 2012 and 2014, with isolation of gram negative bacilli. We performed descriptive and inferential statistics of all variables and multivariate analysis to find associations with mortality. Results: 230 patients were collected, 145 (63%) had isolation of resistant gram negative bacilli. Table 1 shows the general characteristics of both groups found with patients with resistant negative grams with lower age, with no differences in comorbidity, severity score and origin of infection. Resistant gram negative was more frequent in case of nosocomial infection (49 Vs 30%, p &lt; 0. 001). There were no differences in microbiological isolation, except for sensitive E. coli (28 Vs 59%, p &lt; 0. 001), Graph 1. In patients with resistant gram negative the time in intensive care was longer, as was the need for ventilation mechanics; Being the last factor associated with mortality (OR 11. 2 IC95% 2. 5 - 49. 8, p 0. 002). Conclusions: Infection with resistant gram negative bacteria is frequent, with no demographic or clinical differences with the group of infection by sensitive germs. It was associated with longer stay in intensive care and time of mechanical ventilation, the latter being the only risk factor associated with mortality.
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.sourcereponame:Repositorio Institucional EdocUR
dc.sourceinstname:Universidad del Rosario
dc.subjectBacilos gram negativos
dc.subjectMortalidad
dc.subjectMultirresistencia
dc.subjectCuidado crítico
dc.subject.ddcIncidencia & prevención de la enfermedad 
dc.titleMortalidad de pacientes con infección por bacilos gram Negativos sensibles versus resistentes en la unidad de cuidado intensivo medico de la Fundación Cardioinfantil.
dc.typemasterThesis
dc.publisherUniversidad del Rosario
dc.creator.degreeEspecialista en Medicina Interna
dc.publisher.programEspecialización en Medicina Interna
dc.publisher.departmentFacultad de Medicina
dc.subject.keywordGram negative bacilli
dc.subject.keywordMortality Multiresistance
dc.subject.keywordcritical care.
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.subject.decsBacterias Gramnegativas
dc.subject.decsInfecciones Bacterianas
dc.subject.decsCuidados Críticos
dc.type.spaTrabajo de grado
dc.rights.accesoAbierto (Texto completo)
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.source.bibliographicCitationEcheverry-Toro L, Rueda Z, et al. Klebsiella pneumoniae multiresistente, factores predisponentes y mortalidad asociada en un hospital universitario de Colombia. Rev Chil Infect. 2012; 29(2):175-182
dc.source.bibliographicCitationNational Nosocomial Infections Surveillance (NNIS) report dsfO-A, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1996;24:380–8
dc.source.bibliographicCitationRoutsy C, Pratikaki M, Platsouka E. Risk factor for carbapenem resistant gram negative bacteremia in intensive care unit patients. Intensive Care Med (2013) 39:1253-1261
dc.source.bibliographicCitationCorrea L, Martino M, Siqueira I. A hospital based matched case control study to identify clinical outcome and clinical factors associated with carbapenem resistant Klebsiella pneumoniae infection. BMC Infectious Diseases. 2013, 13:80
dc.source.bibliographicCitationVilla M, Cortes J, Leal A. Resistance to antibiotics in Pseudomonas Aeruginosa in Colombian Hospitals. Rev Chil Infect. 2013; 30 (6): 605-610
dc.source.bibliographicCitationPitout JD, Thomson KS, Hanson ND, Ehrhardt AF, Moland ES, Sanders CC. Beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob Agents Chemother 1998;42:1350–4
dc.source.bibliographicCitationNordmann P, Guibert M. Extended-spectrum beta-lactamases in Pseudomonas aeruginosa. J Antimicrob Chemother 1998;42:128–31
dc.source.bibliographicCitationCoudron PE, Moland ES, Sanders CC. Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. J Clin Microbiol 1997;35:2593–7
dc.source.bibliographicCitationJacoby GA. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams. Infect Dis Clin North Am 1997;11:875–87
dc.source.bibliographicCitationDu B, Long Y, Liu H, Chen D, Liu D, Xu Y, et al. Extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med 2002;28:1718–23
dc.source.bibliographicCitationCoudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol 2000;38:1791–6
dc.source.bibliographicCitationItokazu GS, Quinn JP, Bell-Dixon C, Kahan FM, Weinstein RA. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis1996;23:779–84
dc.source.bibliographicCitationLee H, Chen C, Wu S. Risk factors and outcome analysis of Acinetobacter baumannii complex bacteremia in critical patients. Crit Care Med. 2014 May;42(5):1081-8
dc.source.bibliographicCitationZheng Y, Wan Y, Zhou L. Risk factors and mortaliy of patients with nosocomial carbapenem resistance Acinetobacter baumanii pneumoniae. American Journal of infection control. 2013; e59-e63
dc.source.bibliographicCitationMagiorakos A, Srinivasan A, Carey R, et al. Multidrug resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Micrbiol Infect 2012; 18:268-281
dc.source.bibliographicCitationTumbarello M, De Pascale G, Antonelli M, et al. Clincal outcomes of Pseudomonas aeruginosa pneumoniae in intensive care unit patients. Intensive care Med. 2013; 39:682-692
dc.source.bibliographicCitationDellinger R, Levy M, Rhodes A. Surviving sepsis campaign: International Guidelines for the management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637
dc.source.bibliographicCitationMorel J, Casoetto J, Jospé R, et al. De-escalation as part of a global strategy of empiric antibiotherapy management. Crit Care. 2010. R:225
dc.source.bibliographicCitationVazquez Guillamet C, Shorr A, Scott M, et al. Using the number needed to treat to asses appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock. Critical Care Medicine. 2014. Ahead of print.
dc.source.bibliographicCitationEcheverry-Toro L, Rueda Z, et al. Klebsiella pneumoniae multiresistente, factores predisponentes y mortalidad asociada en un hospital universitario de Colombia. Rev Chil Infect. 2012; 29(2):175-182
dc.source.bibliographicCitationNational Nosocomial Infections Surveillance (NNIS) report dsfO-A, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1996;24:380–8
dc.source.bibliographicCitationRoutsy C, Pratikaki M, Platsouka E. Risk factor for carbapenem resistant gram negative bacteremia in intensive care unit patients. Intensive Care Med (2013) 39:1253-1261
dc.source.bibliographicCitationCorrea L, Martino M, Siqueira I. A hospital based matched case control study to identify clinical outcome and clinical factors associated with carbapenem resistant Klebsiella pneumoniae infection. BMC Infectious Diseases. 2013, 13:80
dc.source.bibliographicCitationVilla M, Cortes J, Leal A. Resistance to antibiotics in Pseudomonas Aeruginosa in Colombian Hospitals. Rev Chil Infect. 2013; 30 (6): 605-610
dc.source.bibliographicCitationPitout JD, Thomson KS, Hanson ND, Ehrhardt AF, Moland ES, Sanders CC. Beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob Agents Chemother 1998;42:1350–4
dc.source.bibliographicCitationNordmann P, Guibert M. Extended-spectrum beta-lactamases in Pseudomonas aeruginosa. J Antimicrob Chemother 1998;42:128–31
dc.source.bibliographicCitationCoudron PE, Moland ES, Sanders CC. Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. J Clin Microbiol 1997;35:2593–7
dc.source.bibliographicCitationJacoby GA. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams. Infect Dis Clin North Am 1997;11:875–87
dc.source.bibliographicCitationDu B, Long Y, Liu H, Chen D, Liu D, Xu Y, et al. Extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med 2002;28:1718–23
dc.source.bibliographicCitationCoudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol 2000;38:1791–6
dc.source.bibliographicCitationItokazu GS, Quinn JP, Bell-Dixon C, Kahan FM, Weinstein RA. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis1996;23:779–84
dc.source.bibliographicCitationLee H, Chen C, Wu S. Risk factors and outcome analysis of Acinetobacter baumannii complex bacteremia in critical patients. Crit Care Med. 2014 May;42(5):1081-8
dc.source.bibliographicCitationZheng Y, Wan Y, Zhou L. Risk factors and mortaliy of patients with nosocomial carbapenem resistance Acinetobacter baumanii pneumoniae. American Journal of infection control. 2013; e59-e63
dc.source.bibliographicCitationMagiorakos A, Srinivasan A, Carey R, et al. Multidrug resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Micrbiol Infect 2012; 18:268-281
dc.source.bibliographicCitationTumbarello M, De Pascale G, Antonelli M, et al. Clincal outcomes of Pseudomonas aeruginosa pneumoniae in intensive care unit patients. Intensive care Med. 2013; 39:682-692
dc.source.bibliographicCitationDellinger R, Levy M, Rhodes A. Surviving sepsis campaign: International Guidelines for the management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637
dc.source.bibliographicCitationMorel J, Casoetto J, Jospé R, et al. De-escalation as part of a global strategy of empiric antibiotherapy management. Crit Care. 2010. R:225
dc.source.bibliographicCitationVazquez Guillamet C, Shorr A, Scott M, et al. Using the number needed to treat to asses appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock. Critical Care Medicine. 2014. Ahead of print.
dc.source.bibliographicCitationVincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323—9
dc.source.bibliographicCitationKhwannimit B, Bhurayanontachai R. The epidemiology of, and risk factors for, mortality from severe sepsis and septic shock in a tertirary-care university hospital setting. Epidemiol Infect. 2009;137:1333—41
dc.source.bibliographicCitationCheng B, Xie G, Yao S, Wu X, Guo Q, Gu M, et al. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit Care Med. 2007;35:2538—46
dc.source.bibliographicCitationDegoricija V, Sharma M, Legac A, Gradiser M, Sefer S, Vucicevic Z. Survival analysis of 314 episodes of sepsis in Medical Intensive Care Unit in University Hospital: Impact of intensive care unit performance and antimicrobial therapy. Croat Med J. 2006;47:385—97
dc.source.bibliographicCitationAl-Hasan MN1, Eckel-Passow JE, Baddour LM. Bacteremia complicating gram-negative urinary tract infections: a population-based study. J Infect. 2010 Apr;60(4):278-85
dc.source.bibliographicCitationZapata L, Jaimes F, Garces J, Leal H, Yepes MM, Cuervo J, et al. Descripción de una cohorte de pacientes con criterios de síndrome de respuesta inflamatoria sistémica en dos hospitales de tercer nivel. Iatreia 2001;14:26-34 42
dc.source.bibliographicCitationJaimes F, Garcés J, Cuervo J, Ramírez JH, Ramírez F, Estrada JC, et al. Factores pronósticos en el síndrome de respuesta inflamatoria sistémica (SRIS). Desarrollo de un índice de severidad. Acta Medica Colombiana 2001;26:149-157
dc.source.bibliographicCitationGiuffrè M1, Geraci DM, Bonura C, Saporito L, The Increasing Challenge of Multidrug-Resistant Gram-Negative Bacilli: Results of a 5-Year Active Surveillance Program in a Neonatal Intensive Care Unit. Medicine (Baltimore). 2016 Mar;95(10):e3016
dc.source.bibliographicCitationEsteban A, Frutos-Vivar F, Ferguson ND, Penuelas O, Lorente JA, Gordo F, et al. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med. 2007;35:1284-9
dc.source.bibliographicCitationGoldhill DR, Sumner A. Outcome of intensive care patients in a group of British intensive care units. Crit Care Med. 1998;26:1337-45
dc.source.bibliographicCitationKnaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985 Oct;13(10):818-29
dc.source.bibliographicCitationSepsis-related Organ Faliure Assessment) score to describe organ disfunction/faliure. Intensive Care Med 1996; 22: 707-710
dc.source.bibliographicCitationDamas P1, Layios N, Seidel L, Nys M, Melin P, Ledoux D. Severity of ICU-acquired pneumonia according to infectious microorganisms. Intensive Care Med. 2011 Jul;37(7):1128-35
dc.source.bibliographicCitationSilva E, Pedro Mde A, Sogayar AC, Mohovic T, Silva CL, Janiszewski M, et al. Brazilian Sepsis Epidemiological Study (BASES study). Crit Care. 2004;8:R251—60
dc.source.bibliographicCitationZalacain M1, Biedenbach DJ2, Badal RE. Pathogen Prevalence and Antimicrobial Susceptibility Among Enterobacteriaceae Causing Hospital-Associated Intra-abdominal Infections in Adults in the United States (2012-2013). Clin Ther. 2016 May 24. pii: S0149-2918(16)30269-7
dc.source.bibliographicCitationAdam HJ1, DeCorby M, Rennie R, Karlowsky JA, Hoban DJ, Zhanel GG. Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis. 2011 Mar;69(3):307-13
dc.source.bibliographicCitationHuang CT1, Tsai YJ, Tsai PR, Yu CJ, Ko WJ. Epidemiology and Outcome of Severe Sepsis and Septic Shock in Surgical Intensive Care Units in Northern Taiwan. Medicine (Baltimore). 2015 Nov;94(47):e2136
dc.source.bibliographicCitationMacVane SH1. Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections. J Intensive Care Med. 2016 Jan 15
dc.source.bibliographicCitationVasudevan A1, Mukhopadhyay A, Goh EY, Li J, Tambyah PA. Risk factors for infection/colonization caused by resistant Gram negative bacilli in critically ill patients (an observational study of 1633 critically ill patients) Prev Med. 2013;57 Suppl:S70-3. doi: 10.1016/j.ypmed.2012.12.003
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record